Literature DB >> 21372818

Investigating ADAMTS-mediated aggrecanolysis in mouse cartilage.

Heather Stanton1, Suzanne B Golub, Fraser M Rogerson, Karena Last, Christopher B Little, Amanda J Fosang.   

Abstract

Proteolysis of the cartilage proteoglycan aggrecan is a feature of arthritis. We present a method for analyzing aggrecanolysis in in vitro cultures of 3-week-old mouse femoral head cartilage based on traditional methods developed for large animal species. Investigators can choose either a simple analysis that detects several aggrecan fragments released into culture medium only or a more comprehensive study that detects all fragments present in both the medium and the cartilage matrix. The protocol comprises (i) cartilage culture and optional cartilage extraction, (ii) a quick and simple colorimetric assay for quantitating aggrecan and (iii) neoepitope western blotting to identify specific aggrecan fragments partitioning to the medium or cartilage compartments. The crucial difference between the methods for mice and larger animals is that the proportion of aggrecan in a given sample is normalized to total aggrecan rather than to tissue wet weight. This necessary break from tradition arises because tiny volumes of liquid clinging to mouse cartilage can increase the apparent tissue wet weight, causing unacceptable errors. The protocol has broad application for the in vitro analysis of transgenic mice, particularly those with mutations that affect cartilage remodeling, arthritic disease and skeletal development. The protocol is robust, reliable and takes 7-11 d to complete.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21372818     DOI: 10.1038/nprot.2010.179

Source DB:  PubMed          Journal:  Nat Protoc        ISSN: 1750-2799            Impact factor:   13.491


  74 in total

1.  Mature bovine articular cartilage contains abundant aggrecan that is C-terminally truncated at Ala719-Ala720, a site which is readily cleaved by m-calpain.

Authors:  Hidefumi Oshita; John D Sandy; Kiichi Suzuki; Atsushi Akaike; Yun Bai; Tomohiro Sasaki; Katsuji Shimizu
Journal:  Biochem J       Date:  2004-08-15       Impact factor: 3.857

2.  Aggrecan degradation in human cartilage. Evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthritic, and rheumatoid joints.

Authors:  M W Lark; E K Bayne; J Flanagan; C F Harper; L A Hoerrner; N I Hutchinson; I I Singer; S A Donatelli; J R Weidner; H R Williams; R A Mumford; L S Lohmander
Journal:  J Clin Invest       Date:  1997-07-01       Impact factor: 14.808

3.  Global analyses of gene expression in early experimental osteoarthritis.

Authors:  C T G Appleton; V Pitelka; J Henry; F Beier
Journal:  Arthritis Rheum       Date:  2007-06

4.  The eukaryotic genome as an RNA machine.

Authors:  Paulo P Amaral; Marcel E Dinger; Tim R Mercer; John S Mattick
Journal:  Science       Date:  2008-03-28       Impact factor: 47.728

5.  Analysis of aggrecan in human knee cartilage and synovial fluid indicates that aggrecanase (ADAMTS) activity is responsible for the catabolic turnover and loss of whole aggrecan whereas other protease activity is required for C-terminal processing in vivo.

Authors:  J D Sandy; C Verscharen
Journal:  Biochem J       Date:  2001-09-15       Impact factor: 3.857

6.  Development of a novel clinical biomarker assay to detect and quantify aggrecanase-generated aggrecan fragments in human synovial fluid, serum and urine.

Authors:  C A Swearingen; J W Carpenter; R Siegel; I J Brittain; J Dotzlaf; T B Durham; J L Toth; D A Laska; J Marimuthu; C Liu; D P Brown; Q L Carter; M R Wiley; K L Duffin; P G Mitchell; K Thirunavukkarasu
Journal:  Osteoarthritis Cartilage       Date:  2010-07-13       Impact factor: 6.576

Review 7.  Wnt signaling in cartilage development and degeneration.

Authors:  Jang-Soo Chun; Hwanhee Oh; Siyoung Yang; Meeyoung Park
Journal:  BMB Rep       Date:  2008-07-31       Impact factor: 4.778

8.  Immunological determinants of proteoglycans. Antibodies against the unsaturated oligosaccharide products of chondroitinase ABC-digested cartilage proteoglycans.

Authors:  J E Christner; B Caterson; J R Baker
Journal:  J Biol Chem       Date:  1980-08-10       Impact factor: 5.157

9.  Monoclonal antibodies that specifically recognize neoepitope sequences generated by 'aggrecanase' and matrix metalloproteinase cleavage of aggrecan: application to catabolism in situ and in vitro.

Authors:  C E Hughes; B Caterson; A J Fosang; P J Roughley; J S Mort
Journal:  Biochem J       Date:  1995-02-01       Impact factor: 3.857

10.  Simultaneous preparation and quantitation of proteoglycans by precipitation with alcian blue.

Authors:  S Björnsson
Journal:  Anal Biochem       Date:  1993-05-01       Impact factor: 3.365

View more
  28 in total

1.  Cartilage-specific deletion of Alk5 gene results in a progressive osteoarthritis-like phenotype in mice.

Authors:  Q Wang; Q Y Tan; W Xu; H B Qi; D Chen; S Zhou; Z H Ni; L Kuang; J Y Guo; J L Huang; X X Wang; Z Q Wang; N Su; L Chen; B Chen; W L Jiang; Y Gao; H G Chen; X L Du; Y L Xie; L Chen
Journal:  Osteoarthritis Cartilage       Date:  2017-07-14       Impact factor: 6.576

2.  Mediation of Cartilage Matrix Degeneration and Fibrillation by Decorin in Post-traumatic Osteoarthritis.

Authors:  Qing Li; Biao Han; Chao Wang; Wei Tong; Yulong Wei; Wei-Ju Tseng; Li-Hsin Han; X Sherry Liu; Motomi Enomoto-Iwamoto; Robert L Mauck; Ling Qin; Renato V Iozzo; David E Birk; Lin Han
Journal:  Arthritis Rheumatol       Date:  2020-07-08       Impact factor: 10.995

3.  Effects of stimulated aggrecanolysis on nanoscale morphological and mechanical properties of wild-type and aggrecanase-resistant mutant mice cartilages.

Authors:  Md Hemayet Uddin; Huabin Wang; Fraser M Rogerson; Peter Vee-Sin Lee; Xuehua Zhang
Journal:  Eur Phys J E Soft Matter       Date:  2017-08-16       Impact factor: 1.890

4.  Changes in the chondrocyte and extracellular matrix proteome during post-natal mouse cartilage development.

Authors:  Richard Wilson; Emma L Norris; Bent Brachvogel; Constanza Angelucci; Snezana Zivkovic; Lavinia Gordon; Bianca C Bernardo; Jacek Stermann; Kiyotoshi Sekiguchi; Jeffrey J Gorman; John F Bateman
Journal:  Mol Cell Proteomics       Date:  2011-10-11       Impact factor: 5.911

5.  Use of cartilage derived from murine induced pluripotent stem cells for osteoarthritis drug screening.

Authors:  Vincent P Willard; Brian O Diekman; Johannah Sanchez-Adams; Nicolas Christoforou; Kam W Leong; Farshid Guilak
Journal:  Arthritis Rheumatol       Date:  2014-11       Impact factor: 10.995

6.  Controlled induction and targeted elimination of p16INK4a-expressing chondrocytes in cartilage explant culture.

Authors:  Garrett A Sessions; Michaela E Copp; Jie-Yu Liu; Margaret A Sinkler; Susan D'Costa; Brian O Diekman
Journal:  FASEB J       Date:  2019-08-13       Impact factor: 5.191

7.  Mast cell-restricted, tetramer-forming tryptases induce aggrecanolysis in articular cartilage by activating matrix metalloproteinase-3 and -13 zymogens.

Authors:  Natalia J Magarinos; Katherine J Bryant; Amanda J Fosang; Roberto Adachi; Richard L Stevens; H Patrick McNeil
Journal:  J Immunol       Date:  2013-06-24       Impact factor: 5.422

8.  Identification of fibroblast growth factor-18 as a molecule to protect adult articular cartilage by gene expression profiling.

Authors:  Yoshifumi Mori; Taku Saito; Song Ho Chang; Hiroshi Kobayashi; Christoph H Ladel; Hans Guehring; Ung-il Chung; Hiroshi Kawaguchi
Journal:  J Biol Chem       Date:  2014-02-27       Impact factor: 5.157

9.  Transcriptional induction of ADAMTS5 protein by nuclear factor-κB (NF-κB) family member RelA/p65 in chondrocytes during osteoarthritis development.

Authors:  Hiroshi Kobayashi; Makoto Hirata; Taku Saito; Shozo Itoh; Ung-il Chung; Hiroshi Kawaguchi
Journal:  J Biol Chem       Date:  2013-08-20       Impact factor: 5.157

10.  Effects of low dose X-ray irradiation on porcine articular cartilage explants.

Authors:  Carl Alexander Lindburg; Jeffrey S Willey; Delphine Dean
Journal:  J Orthop Res       Date:  2013-08-01       Impact factor: 3.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.